Medical Oncologist
Thyroid cancer treatment
Lenvatinib for Thyroid Cancer: — What RAI-Refractory Means for You
Lenvatinib is not prescribed for early thyroid cancer. It is used in a specific setting: advanced differentiated thyroid cancer that has stopped responding to radioactive iodine. Understanding which situation applies to you is the first question your oncologist will answer.
Medically reviewed by Dr. Bharati Devi Gorantla, Medical Oncologist, MBBS · MD · DM (Adyar, Chennai) · ECMO · MRCP SCE (UK) · Last reviewed August 2026
- Not for early-stage thyroid cancer — Most thyroid cancers are treated with surgery and radioactive iodine — lenvatinib is not part of that pathway.
- For RAI-refractory disease only — It is prescribed when your cancer has grown despite radioactive iodine, or no longer takes it up.
- An oral capsule, not an infusion — Lenvatinib is swallowed, not given by injection or drip. Your team will confirm your dose and schedule.
- Requires close monitoring — Blood pressure, kidney function and thyroid levels need regular checks during treatment.
17+
Cancer Specialists
on Panel
on Panel
96.9%
Breast Cancer
Survival Rate*
Survival Rate*
15,000+
Patients
Treated
Treated
4.8★
Google Rating
(800+ reviews)
(800+ reviews)
Lenvatinib (Lenvima) is an oral capsule for advanced differentiated thyroid cancer that has stopped responding to radioactive iodine. It is not used for early-stage thyroid cancer, which is treated with surgery and radioactive iodine. NCCN and ESMO list it as a standard option for the radioactive-iodine-refractory setting.
Is lenvatinib used for early-stage thyroid cancer?
No. This is the most common confusion patients bring to clinic.
Most thyroid cancers — papillary and follicular are the most common — are diagnosed early, treated with surgery and radioactive iodine, and do not require lenvatinib at any point.
Lenvatinib enters the picture only when a differentiated thyroid cancer has spread or grown despite radioactive iodine, or when scans show the tumour is no longer absorbing iodine at all. That situation is called radioactive-iodine-refractory.
If your oncologist has prescribed lenvatinib, it means your cancer has reached that stage. It does not mean the earlier treatment failed because of something that could have been done differently.
What do the medical terms on your referral mean?
- RAI-refractory
- Radioactive iodine works by accumulating in thyroid tissue and damaging it. RAI-refractory means your cancer has either stopped taking up iodine, or has continued to grow even when it does. Lenvatinib is designed for this situation.
- Differentiated thyroid cancer
- Papillary and follicular thyroid cancers are called differentiated because their cells still resemble normal thyroid tissue. Lenvatinib is approved for these types, and for Hürthle cell carcinoma, when they become RAI-refractory.
- Kinase inhibitor
- Lenvatinib blocks proteins called kinases that cancer cells use to build new blood vessels and divide. Without those signals, tumour growth slows. It works differently from chemotherapy, which targets actively dividing cells broadly.
- Progression
- On imaging reports, progression means the tumour has grown or new areas of spread have appeared since the previous scan. Progression despite radioactive iodine is one of the main criteria for considering lenvatinib.
What should be in place before you start lenvatinib?
- Your cancer type has been confirmed as papillary, follicular or Hürthle cell thyroid cancer
- Imaging or an iodine uptake test has shown low or absent iodine uptake in the tumour
- Your cancer has grown or spread despite radioactive iodine treatment
- A baseline blood pressure check, kidney function test and urine protein test have been done
- Your current medications and supplements have been reviewed for interactions
Meet the Specialists
17+ senior cancer specialists. One panel for your case.
Trained at AIIMS, Tata Memorial, and leading international centres. Combined 150+ years of experience. Every complex case is reviewed by 3+ of them — together.
Medical Oncologist
Dr. C. Raghavendra Reddy
MBBS(Gold Medal), DNB(General Medicine), DM(Medical Oncology)(Gold Medal)
Medical Oncologist
Dr. Bharati Devi Gorantla
MBBS, MD(General Medicine), DM(Medical Oncology)(Adyar,Chennai), ECMO, MRCP SCE(UK)
Medical Oncologist
Dr. Owais Mohammed
MBBS, MD (General Medicine), DrNB (Medical Oncology), ECMO, MRCP SCE (Medical Oncology) (UK)
Medical Oncologist
Medical Oncologist
Surgical Oncologist
Dr. Muralidhar Muddusetty
MBBS (AIIMS), MS (Surgery) (AIIMS), DNB (Surgical Oncology), MRCS (Edinburgh)
Surgical Oncologist
Surgical Oncologist
Surgical Oncologist
Dr. Vinay Mamidala
MBBS, MS(General Surgery), M.Ch(Surgical Oncology), FMAS, FARIS(Ongoing)
Surgical Oncologist
Radiation Oncologist
Radiation Oncologist
Radiation Oncologist
Hematologist
Interventional Radiologist
Dr. Mohammed Imran
Surgical Oncologist
Dr. Vajja Sandeep Kumar
MBBS, MS (General Surgery), DrNB (Surgical Oncology), FALS Oncology
Surgical Oncologist
Want a specific doctor for your case? Mention them when booking.
Book Free ConsultationBook an appointment with our specialist
Share your name and number — we'll call you back within 30 minutes to schedule your consultation.
You do not have to work this out alone
A 45-minute consultation with a specialist who treats this every week.
What happens when you start lenvatinib?
Baseline checks
Before your first dose, your team checks your blood pressure, kidney and liver function, urine protein, thyroid hormone levels and heart function. These give a starting point to compare against once treatment begins.
Starting the capsule
Lenvatinib is taken by mouth as a capsule. Your team will confirm your specific dose, when to take it, and whether food makes a difference. Do not adjust the dose yourself.
Blood pressure monitoring in early weeks
Blood pressure is the side effect that needs the most attention at the start. Your team will tell you how often to check it and at what reading to call them. Some patients need a blood pressure medication added at this point.
Dose review if needed
If a side effect becomes difficult, the dose is often reduced rather than the treatment stopped. A reduced dose is still active treatment. Your team adjusts based on tolerability, not on tumour response alone.
Response imaging
Scans are repeated at intervals set by your team to check whether the tumour is stable or shrinking. Your oncologist will explain when the first reassessment is planned.
What side effects should you expect on lenvatinib?
High blood pressure is the most common side effect and can develop within the first few weeks. Your team monitors it closely and may start a blood pressure medication at the same time as lenvatinib.
Fatigue, reduced appetite, loose stools and weight loss are common, particularly in the first months. These often improve over time or after a dose adjustment.
Some people develop hand-foot syndrome — redness, tenderness or peeling on the palms or soles. Reporting it early gives your team the chance to manage it before it becomes severe.
Lenvatinib can alter your thyroid hormone levels even if part of your thyroid remains. Your team will check thyroid function regularly and adjust your replacement medication if needed.
What does your team watch for while you are on lenvatinib?
Blood pressure is checked frequently, especially in the early weeks. Your team will give you a target reading and tell you clearly when to call.
Blood tests check kidney and liver function, protein in the urine and electrolyte levels on a schedule your oncologist sets.
Thyroid hormone levels are monitored because lenvatinib can change how much replacement thyroxine you need.
Imaging is repeated at intervals to assess tumour response. The schedule is specific to your situation.
Explore 100 more Gastrointestinal & Liver Targeted Medicines topics
Drug Deep Dive: Lenvatinib (Lenvima)
- Blood Pressure Spikes on Lenvatinib: The Critical First Two Weeks
- Diarrhoea, Appetite Loss and Rapid Weight Drop on Lenvatinib
- Diet and Nutrition While on Lenvatinib
- Dose Reductions on Lenvatinib: Why Most Patients Need One
- Drug, Food and Supplement Interactions With Lenvatinib
- Fertility, Pregnancy and Contraception on Lenvatinib
- Hand-Foot Skin Reaction on Lenvatinib: Prevention and Relief
- How Does Lenvatinib Work? The Multi-Kinase Angiogenesis Inhibitor Explained
- How Long Does Lenvatinib Take to Work?
- How Long Will You Stay on Lenvatinib?
- Lenvatinib (Lenvima, Lenvanix): The Complete Patient Guide
- Lenvatinib Myths: Side Effects, Dose Cuts and 'Giving Up'
- Lenvatinib Price in India: Brand, Generic and Monthly Cost
- Lenvatinib Side Effects: The Complete List and Timeline
- Lenvatinib Success Rate and Survival: An Honest Look at the Numbers
- Lenvatinib With Immunotherapy: The Combination Explained
- Lenvatinib for Radioactive-Iodine-Refractory Thyroid Cancer
- Lenvatinib in Elderly Patients and Those With Other Illnesses
- Lenvatinib vs Sorafenib for Liver Cancer: Which Comes First?
- Taking Lenvatinib: Food, Timing and What to Do If You Miss a Dose
- Tests and Monitoring While You Are on Lenvatinib
- When Lenvatinib Stops Working: Resistance and What Comes Next
- Who Is Eligible for Lenvatinib? Liver, Thyroid, Kidney and Endometrial Cancer
- Will Insurance or a Government Scheme Pay for Lenvatinib?
- Work, Travel and Daily Life on Lenvatinib
Drug Deep Dive: Bevacizumab (Avastin)
- Avastin vs Biosimilar Bevacizumab in India: Cost and Safety
- Bevacizumab (Avastin and biosimilars): The Complete Patient Guide
- Bevacizumab Infusion Day: Premedication, Duration and What to Expect
- Bevacizumab Myths: 'It Dissolves Tumours' and Other Misconceptions
- Bevacizumab Price in India: Innovator, Biosimilar and Cost Per Cycle
- Bevacizumab Side Effects: The Complete List and Timeline
- Bevacizumab Success Rate and Survival: An Honest Look at the Numbers
- Bevacizumab With Chemotherapy: Which Combinations and Why
- Bevacizumab in Elderly Patients and Those With Other Illnesses
- Bevacizumab in Eye Disease vs Cancer: Same Drug, Very Different Dose
- Bleeding, Bowel Perforation and Wound Healing Risks on Bevacizumab
- Diet and Nutrition While on Bevacizumab
- Drug, Food and Supplement Interactions With Bevacizumab
- Fertility, Pregnancy and Contraception on Bevacizumab
- High Blood Pressure on Bevacizumab: Monitoring and Treatment
- How Does Bevacizumab Work? The Anti-VEGF Angiogenesis Inhibitor Explained
- How Long Does Bevacizumab Take to Work?
- How Long Will You Stay on Bevacizumab?
- Protein in Your Urine on Bevacizumab: What the Report Means
- Surgery While on Bevacizumab: The 28-Day Rule
- Tests and Monitoring While You Are on Bevacizumab
- When Bevacizumab Stops Working: Resistance and What Comes Next
- Who Is Eligible for Bevacizumab? Colorectal, Lung, Ovarian, Cervical and Brain Cancer
- Will Insurance or a Government Scheme Pay for Bevacizumab?
- Work, Travel and Daily Life on Bevacizumab
Drug Deep Dive: Cetuximab (Erbitux)
- Cetuximab (Erbitux): The Complete Patient Guide
- Cetuximab Infusion Day: Premedication, Duration and What to Expect
- Cetuximab Infusion Reactions: Why the First Dose Is Given Slowly
- Cetuximab Myths: 'The Worse the Rash, the Better' and Other Half-Truths
- Cetuximab Price in India: Innovator, Biosimilar and Cost Per Cycle
- Cetuximab Side Effects: The Complete List and Timeline
- Cetuximab Success Rate and Survival: An Honest Look at the Numbers
- Cetuximab With FOLFIRI, FOLFOX and Radiation
- Cetuximab in Colorectal vs Head and Neck Cancer: Different Roles
- Cetuximab in Elderly Patients and Those With Other Illnesses
- Cetuximab vs Bevacizumab in Colorectal Cancer: Which and When
- Diet and Nutrition While on Cetuximab
- Drug, Food and Supplement Interactions With Cetuximab
- Fertility, Pregnancy and Contraception on Cetuximab
- How Does Cetuximab Work? The Anti-EGFR Monoclonal Antibody Explained
- How Long Does Cetuximab Take to Work?
- How Long Will You Stay on Cetuximab?
- Low Magnesium on Cetuximab: Cramps, Fatigue and Monthly Testing
- Tests and Monitoring While You Are on Cetuximab
- The Cetuximab Rash: Severity, Treatment and Why It Predicts Response
- When Cetuximab Stops Working: Resistance and What Comes Next
- Who Is Eligible for Cetuximab? RAS Wild-Type Colorectal Cancer and Head and Neck Cancer
- Why Cetuximab Only Works in RAS Wild-Type, Left-Sided Tumours
- Will Insurance or a Government Scheme Pay for Cetuximab?
- Work, Travel and Daily Life on Cetuximab
Drug Deep Dive: Sorafenib (Nexavar)
- Blood Pressure, Rash and Hair Thinning on Sorafenib
- Diarrhoea on Sorafenib: Controlling It Without Stopping Treatment
- Diet and Nutrition While on Sorafenib
- Drug, Food and Supplement Interactions With Sorafenib
- Fertility, Pregnancy and Contraception on Sorafenib
- Hand-Foot Skin Reaction on Sorafenib: Prevention From Day One
- How Does Sorafenib Work? The Multi-Kinase Angiogenesis Inhibitor Explained
- How Long Does Sorafenib Take to Work?
- How Long Will You Stay on Sorafenib?
- Sorafenib (Nexavar, Soranib): The Complete Patient Guide
- Sorafenib Myths: Dose Reduction, 'Last Resort' and Generic Quality
- Sorafenib Price in India: Brand, Generic and Monthly Cost
- Sorafenib Side Effects: The Complete List and Timeline
- Sorafenib Success Rate and Survival: An Honest Look at the Numbers
- Sorafenib With Cirrhosis: Why Child-Pugh Status Decides Eligibility
- Sorafenib With TACE and Other Liver-Directed Treatments
- Sorafenib in Elderly Patients and Those With Other Illnesses
- Sorafenib in Liver, Kidney and Thyroid Cancer: Three Different Uses
- Sorafenib vs Lenvatinib for Liver Cancer: Cost, Tolerability and Evidence
- Taking Sorafenib: Food, Timing and What to Do If You Miss a Dose
- Tests and Monitoring While You Are on Sorafenib
- When Sorafenib Stops Working: Resistance and What Comes Next
- Who Is Eligible for Sorafenib? Liver, Kidney and Radioiodine-Refractory Thyroid Cancer
- Will Insurance or a Government Scheme Pay for Sorafenib?
- Work, Travel and Daily Life on Sorafenib
Next step
Still not sure what applies to you?
Send your reports across and a senior medical oncologist will go through what they mean, what is known, and what the options actually are.
Common questions
Frequently asked questions
Why am I getting lenvatinib instead of more radioactive iodine?
Radioactive iodine works by accumulating in thyroid tissue. When scans show your tumour is no longer taking up iodine, or the cancer has continued to grow despite iodine treatment, further radioactive iodine is unlikely to help. Lenvatinib works through a different mechanism — blocking the signals that allow the tumour to build new blood vessels and grow — and is specifically recommended for this RAI-refractory situation in guidance from NCCN, ESMO and CDSCO.
Does lenvatinib cure thyroid cancer?
The aim of lenvatinib in the RAI-refractory setting is to slow growth and control the disease. In a proportion of patients, tumours shrink. In others, the cancer stabilises. Whether it is working for you is assessed through imaging at intervals. Your oncologist will explain what the treatment is intended to achieve in your specific situation and what the evidence says about how it performs for your cancer type.
How long will I need to take lenvatinib?
Lenvatinib is continued for as long as it is controlling the cancer and the side effects are manageable. There is no fixed course length. Treatment is stopped if the cancer grows through it, if side effects cannot be managed even after dose adjustment, or if your circumstances change. Most people take it as an ongoing treatment, with regular imaging to confirm it is still working.
What happens if the side effects become too difficult?
The dose can be reduced in steps, and a reduced dose is still active treatment. Many people continue successfully on a modified dose. If a particular side effect is severe — such as uncontrolled blood pressure or significant protein in the urine — your team may pause treatment while managing it, then restart. Stopping permanently is considered only when side effects cannot be controlled or the treatment is no longer working. Tell your team about side effects early rather than waiting.
Can lenvatinib interact with other medications I take?
Yes. Lenvatinib is processed through specific liver pathways and can interact with certain blood pressure drugs, antifungals and other medications. Tell your oncology team about everything you take before starting — including supplements, vitamins and herbal or Ayurvedic preparations. Some plant-based compounds affect the same liver pathways. Bring a full list to your appointment, and ask your pharmacist to check for interactions as well.
My family member has early thyroid cancer. Should they ask about lenvatinib?
No. Early-stage papillary or follicular thyroid cancer is treated with surgery and, where appropriate, radioactive iodine. Lenvatinib is not part of that treatment pathway. If your family member's oncologist has mentioned lenvatinib, ask specifically whether the cancer has reached the RAI-refractory stage — because that changes the clinical picture entirely, and understanding which stage applies is the right question to bring to the next appointment.